13F COMBINATION REPORT
TPG GP A, LLC
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001999371-25-011364
Total Value
$1.88B
Positions
9
Other Managers
0
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | LifeStance Health Group Inc | LFST | 160,711,618 | $830.9M | 44.29% |
| 2 | Life Time Group Holdings Inc | LTH | 21,404,488 | $649.2M | 34.61% |
| 3 | Sionna Therapeutics Inc | SION | 6,744,962 | $117.0M | 6.24% |
| 4 | Amneal Pharmaceuticals Inc | AMRX | 12,328,767 | $99.7M | 5.32% |
| 5 | CeriBell Inc. | CBLL | 3,967,422 | $74.3M | 3.96% |
| 6 | TPG RE Fin Tr Inc | TPGXL | 7,086,779 | $54.7M | 2.92% |
| 7 | Bicara Therapeutics Inc. | BCAX | 3,010,425 | $28.0M | 1.49% |
| 8 | Allogene Therapeutics Inc | ALLO | 18,716,306 | $21.1M | 1.13% |
| 9 | Rallybio Corp | RLYB | 3,028,414 | $1.0M | 0.05% |